August 8, 2025 · Form 4 insider transaction
Rubric Capital Management LP bought 2,387,225 shares of Heron Therapeutics, Inc. at $1.50 per share, a transaction worth $3.58M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital.; The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.